Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Adaptive Biotechnologies Corp (ADPT)

Adaptive Biotechnologies Corp (ADPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,384,627
  • Shares Outstanding, K 152,665
  • Annual Sales, $ 276,980 K
  • Annual Income, $ -59,500 K
  • EBIT $ -55 M
  • EBITDA $ -44 M
  • 60-Month Beta 2.18
  • Price/Sales 8.62
  • Price/Cash Flow N/A
  • Price/Book 10.61

Options Overview Details

View History
  • Implied Volatility 274.02% (+67.13%)
  • Historical Volatility 62.74%
  • IV Percentile 100%
  • IV Rank 100.00%
  • IV High 274.02% on 02/11/26
  • IV Low 58.02% on 06/13/25
  • Expected Move (DTE 8) 1.96 (12.84%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 121
  • Put/Call OI Ratio 0.18
  • Today's Open Interest 3,179
  • Open Int (30-Day) 2,896
  • Expected Range 13.28 to 17.19

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate -0.16
  • Number of Estimates 4
  • High Estimate -0.14
  • Low Estimate -0.17
  • Prior Year -0.20
  • Growth Rate Est. (year over year) +20.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.85 +2.83%
on 02/11/26
19.80 -22.88%
on 02/03/26
-2.99 (-16.37%)
since 01/12/26
3-Month
13.28 +14.98%
on 11/18/25
20.76 -26.45%
on 11/25/25
+0.77 (+5.31%)
since 11/12/25
52-Week
6.26 +144.12%
on 03/11/25
20.76 -26.45%
on 11/25/25
+7.72 (+102.25%)
since 02/12/25

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Adaptive Biotechnologies Corporation is a commercial-stage biotech company. It develops and commercializes immune-driven clinical products to transform the diagnosis and treatment of disease. The company's product pipeline includes immunoSEQ, clonoSEQ and cellular therapy which are in clinical stage....

See More

Key Turning Points

3rd Resistance Point 17.18
2nd Resistance Point 16.56
1st Resistance Point 16.09
Last Price 15.22
1st Support Level 15.00
2nd Support Level 14.38
3rd Support Level 13.91

See More

52-Week High 20.76
Fibonacci 61.8% 15.22
Last Price 15.22
Fibonacci 50% 13.51
Fibonacci 38.2% 11.80
52-Week Low 6.26

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar